Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' NADALGINARD B' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 44 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. PUIGSERVER P; RIBOT J; SERRA F; GIANOTTI M; BONET ML; NADALGINARD B; PALOU A
      INVOLVEMENT OF THE RETINOBLASTOMA PROTEIN IN BROWN AND WHITE ADIPOCYTE CELL-DIFFERENTIATION - FUNCTIONAL AND PHYSICAL ASSOCIATION WITH THE ADIPOGENIC TRANSCRIPTION FACTOR C EBP-ALPHA/

      European journal of cell biology
    2. ENDO T; NADALGINARD B
      REVERSAL OF MYOGENIC TERMINAL DIFFERENTIATION BY SV40 LARGE T-ANTIGENRESULTS IN MITOSIS AND APOPTOSIS

      Journal of Cell Science
    3. LEE Y; NADALGINARD B; MAHDAVI V; IZUMO S
      MYOCYTE-SPECIFIC ENHANCER FACTOR-2 AND THYROID-HORMONE RECEPTOR ASSOCIATE AND SYNERGISTICALLY ACTIVATE THE ALPHA-CARDIAC MYOSIN HEAVY-CHAINGENE

      Molecular and cellular biology
    4. VONHARSDORF R; EDWARDS JG; SHEN YT; KUDEJ RK; DIETZ R; LEINWAND LA; NADALGINARD B; VATNER SF
      IDENTIFICATION OF A CIS-ACTING REGULATORY ELEMENT CONFERRING INDUCIBILITY OF THE ATRIAL-NATRIURETIC-FACTOR GENE IN ACUTE PRESSURE-OVERLOAD

      The Journal of clinical investigation
    5. CARDOSO MC; JOSEPH C; RAHN HP; REUSCH R; NADALGINARD B; LEONHARDT H
      MAPPING AND USE OF A SEQUENCE THAT TARGETS DNA-LIGASE-I TO SITES OF DNA-REPLICATION IN-VIVO

      The Journal of cell biology
    6. SUBRAMANIAN SV; NADALGINARD B
      EARLY EXPRESSION OF THE DIFFERENT ISOFORMS OF THE MYOCYTE ENHANCER FACTOR-II (MEF2) PROTEIN IN MYOGENIC AS WELL TPS NONMYOGENIC CELL LINEAGES DURING MOUSE EMBRYOGENESIS

      Mechanisms of development
    7. WANG J; HUANG Q; TANG W; NADALGINARD B
      E2F1 INHIBITION OF TRANSCRIPTION ACTIVATION BY MYOGENIC BASIC HELIX-LOOP-HELIX REGULATORS

      Journal of cellular biochemistry
    8. RUIZ ML; LONDON B; NADALGINARD B
      CLONING AND CHARACTERIZATION OF AN OLFACTORY CYCLIC NUCLEOTIDE-GATED CHANNEL EXPRESSED IN MOUSE HEART

      Journal of Molecular and Cellular Cardiology
    9. WANG J; HELIN K; JIN P; NADALGINARD B
      INHIBITION OF IN-VITRO MYOGENIC DIFFERENTIATION BY CELLULAR TRANSCRIPTION FACTOR E2F1

      Cell growth & differentiation
    10. TAM SKC; GU W; NADALGINARD B
      MOLECULAR CARDIOMYOPLASTY - POTENTIAL CARDIAC GENE-THERAPY FOR CHRONIC HEART-FAILURE

      Journal of thoracic and cardiovascular surgery
    11. GAUDIN C; ISHIKAWA Y; WIGHT DC; MAHDAVI V; NADALGINARD B; WAGNER TE; VATNER DE; HOMCY CJ
      OVEREXPRESSION OF G(S-ALPHA) PROTEIN IN THE HEARTS OF TRANSGENIC MICE

      The Journal of clinical investigation
    12. LONDON B; HILL JA; NGUYEN H; SCHIEFERL S; NADALGINARD B
      IN-VIVO MUTAGENESIS OF THE MOUSE HEART - TARGETED REPLACEMENT OF THE MURINE DELAYED RECTIFIER POTASSIUM CHANNEL MKV1.5 WITH THE RAT-BRAIN DELAYED RECTIFIER CHANNEL RKV1.1

      Circulation
    13. WANG J; NADALGINARD B
      REGULATION OF CYCLINS AND P34(CDC2) EXPRESSION DURING TERMINAL DIFFERENTIATION OF C2C12 MYOCYTES

      Biochemical and biophysical research communications
    14. FAN THM; KIM CH; KELLY PF; NADALGINARD B; LIANG CS
      REDUCTION OF NA,K-ATPASE IN THE FAILING MYOCARDIUM IS LIMITED TO THE ALPHA-3 ISOFORM

      Journal of the American College of Cardiology
    15. ANDRES V; KAUSHAL S; CERVERA M; NADALGINARD B
      IN-VITRO SELECTION OF OPTIMAL DNA TARGETS BY CARDIAC AND SKELETAL-MUSCLE MEF2 ISOFORMS

      Journal of cellular biochemistry
    16. KAUSHAL S; MAHDAVI V; NADALGINARD B
      MYOGENIC FUNCTION OF MEF2 AND CROSS REGULATORY NETWORK WITH THE MYOGENIC BHI-H-FACTORS

      Journal of cellular biochemistry
    17. LEE YS; NADALGINARD B; MAHDAVI V
      MYOCYTE-SPECIFIC ENHANCER-BINDING FACTOR-II (MEF2) AND THYROID-HORMONE RECEPTOR (TR) ASSOCIATE AND SYNERGISTICALLY ACTIVATE THE ALPHA-CARDIAC MYOSIN HEAVY-CHAIN GENE

      Journal of cellular biochemistry
    18. LEONHARDT H; CARDOSO MC; NADALGINARD B
      FUNCTIONAL-ORGANIZATION OF THE MAMMALIAN NUCLEUS - A LINK BETWEEN CELL-CYCLE REGULATION AND DNA-REPLICATION

      Journal of cellular biochemistry
    19. MAYER SA; BUVOLI M; NADALGINARD B
      PURINE SEQUENCE ELEMENTS IN SMOOTH MUSCLE-SPECIFIC ALPHA-TROPOMYOSIN EXON-2 BIND A NOVEL 120 KD PROTEIN AND ACTIVATE 3' SPLICE-SITE SELECTION

      Journal of cellular biochemistry
    20. GOODING C; ROBERTS GC; MOREAU G; NADALGINARD B; SMITH CWJ
      SMOOTH MUSCLE-SPECIFIC SWITCHING OF ALPHA-TROPOMYOSIN MUTUALLY EXCLUSIVE EXON SELECTION BY SPECIFIC-INHIBITION OF THE STRONG DEFAULT EXON

      EMBO journal
    21. KAUSHAL S; SCHNEIDER JW; NADALGINARD B; MAHDAVI V
      ACTIVATION OF THE MYOGENIC LINEAGE BY MEF2A, A FACTOR THAT INDUCES AND COOPERATES WITH MYOD

      Science
    22. SCHNEIDER JW; GU W; ZHU L; MAHDAVI V; NADALGINARD B
      REVERSAL OF TERMINAL DIFFERENTIATION MEDIATED BY P107 IN RB(- -) MUSCLE-CELLS/

      Science
    23. YANG JH; CEDERGREN R; NADALGINARD B
      CATALYTIC ACTIVITY OF AN RNA DOMAIN DERIVED FROM THE U6-U4 RNA COMPLEX

      Science
    24. CHIARA MD; CHAMPIONARNAUD P; BUVOLI M; NADALGINARD B; REED R
      SPECIFIC PROTEIN-PROTEIN INTERACTIONS BETWEEN THE ESSENTIAL MAMMALIANSPLICEOSOME-ASSOCIATED PROTEINS SAP-61 AND SAP-114

      Proceedings of the National Academy of Sciences of the United Statesof America
    25. VONHARSDORF R; SHEN YT; DIETZ R; NADALGINARD B; VATNER S
      IDENTIFICATION OF A CIS-ACTING REGULATORY ELEMENT WHICH CONFERS INDUCIBILITY OF THE ANF-GENE IN DEVELOPING CARDIAC-HYPERTROPHY

      Circulation
    26. VONHARSDORF R; SHEN YT; DIETZ R; NADALGINARD B; VATNER S
      IDENTIFICATION OF A CIS-ACTING REGULATORY ELEMENT WHICH CONFERS INDUCIBILITY OF THE ANF-GENE IN DEVELOPING CARDIAC-HYPERTROPHY

      Circulation
    27. LONDON B; HILL JA; NADALGINARD B; LOGOTHETIS DA
      CLONING AND EXPRESSION OF THE GENE ENCODING THE MURINE DELAYED RECTIFIER POTASSIUM CHANNEL KV1.5

      Biophysical journal
    28. BREITBART RE; LIANG CS; SMOOT LB; LAHERU DA; MAHDAVI V; NADALGINARD B
      A 4TH HUMAN MEF2 TRANSCRIPTION FACTOR, HMEF2D, IS AN EARLY MARKER OF THE MYOGENIC LINEAGE

      Development
    29. LOGOTHETIS DE; KAMMEN BF; LINDPAINTNER K; BISBAS D; NADALGINARD B
      GATING CHARGE DIFFERENCES BETWEEN 2 VOLTAGE-GATED K+ CHANNELS ARE DUETO THE SPECIFIC CHARGE CONTENT OF THEIR RESPECTIVE S4 REGIONS

      Neuron
    30. NADALGINARD B; MAHDAVI V
      MOLECULAR MECHANISMS OF CARDIAC GENE-EXPRESSION

      Basic research in cardiology
    31. SMITH CWJ; CHU TT; NADALGINARD B
      SCANNING AND COMPETITION BETWEEN AGS ARE INVOLVED IN 3' SPLICE-SITE SELECTION IN MAMMALIAN INTRONS

      Molecular and cellular biology
    32. NADALGINARD B; MAHDAVI V
      BASIC MECHANISMS OF CARDIAC GENE-EXPRESSION

      European heart journal
    33. KREUTZ R; HUBNER N; FERNANDEZALFONSO MS; GANTEN D; NADALGINARD B; LINDPAINTNER K
      DECREASED ANGIOTENSIN-CONVERTING ENZYME (ACE) ACTIVITY IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS (SHRSP) IS GENETICALLY-DETERMINED

      Hypertension
    34. CARDOSO MC; LEONHARDT H; NADALGINARD B
      REVERSAL OF TERMINAL DIFFERENTIATION AND CONTROL OF DNA-REPLICATION -CYCLIN-A AND CDK2 SPECIFICALLY LOCALIZE AT SUBNUCLEAR SITES OF DNA-REPLICATION

      Cell
    35. GONG BJ; MABUCHI K; TAKAHASHI K; NADALGINARD B; TAO T
      CHARACTERIZATION OF WILD-TYPE AND MUTANT CHICKEN GIZZARD ALPHA-CALPONIN EXPRESSED IN ESCHERICHIA-COLI

      Journal of Biochemistry
    36. VATNER SF; LEINWAND LA; LIBBY P; NADALGINARD B; SCHWARTZ K; STRAUSS HC
      ALL MANUSCRIPTS ARE NOT CREATED EQUAL - THE EXPEDITED PUBLICATION

      Circulation research
    37. HILL JA; LONDON B; NGUYEN H; NADALGINARD B
      POTASSIUM CHANNEL GENE TARGETING BY HOMOLOGOUS RECOMBINATION

      Circulation
    38. SCHNEIDER JW; GU W; MAHDAVI V; NADALGINARD B
      ABERRANTLY-INDUCED P107 RESCUES MYOGENESIS BUT NOT GROWTH-ARREST IN RB- RB- SKELETAL-MUSCLE CELLS/

      Circulation
    39. TAKAHASHI K; TAKAGI M; OHGAMI K; NAKAI M; KOJIMA A; NADALGINARD B; SHIBATA N
      INHIBITION OF SMOOTH-MUSCLE CELL-MIGRATION AND PROLIFERATION CAUSED BY TRANSFECTION OF THE HUMAN CALPONIN GENE IS ASSOCIATED WITH ENHANCED CELL-MATRIX ADHESION AND REDUCED PDGF RESPONSIVENESS

      Circulation
    40. GU W; SCHNEIDER J; MAHDAVI V; NADALGINARD B
      DOWN-REGULATION OF TUMOR-SUPPRESSOR POCKET PROTEINS REVERSES THE TERMINALLY DIFFERENTIATED STATE OF MUSCLE-CELLS

      Circulation
    41. LEE Y; NADALGINARD B; MAHDAVI V
      MYOCYTE-SPECIFIC ENHANCER-BINDING FACTOR-2 (MEF2) AND THYROID-HORMONERECEPTOR (TR) ASSOCIATE AND SYNERGISTICALLY ACTIVATE THE ALPHA-CARDIAC MYOSIN HEAVY-CHAIN GENE

      Circulation
    42. TAM SKC; GU W; MAHDAVI V; NADALGINARD B
      TUMOR-SUPPRESSOR GENES AND CELL-CYCLE REGULATORS EXPRESSION IN CARDIAC DEVELOPMENT AND HYPERTROPHY

      Circulation
    43. KREUTZ R; LINDPAINTNER K; PFEFFER MA; STAMPFER MJ; GAZIANO JM; GRODSTEIN F; BURING J; LAMOTTE F; HENNEKENS CH; NADALGINARD B; BRAUNWALD E
      ANGIOTENSIN-CONVERTING ENZYME GENOTYPE AND RISK FOR CORONARY HEART-DISEASE

      Circulation
    44. SATLER C; WALSH E; KORF B; GINSBURG G; KUNKEL L; NADALGINARD B
      CLEAR EVIDENCE FOR GENETIC-HETEROGENEITY AMONG LARGE MULTIGENERATIONAL FAMILIES WITH LONG QT SYNDROME

      Circulation


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/01/21 alle ore 07:23:51